Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy (Q83486149)
Jump to navigation
Jump to search
scientific article published on 21 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy |
scientific article published on 21 February 2012 |
Statements
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy (English)
Juan Carlos Barros-Tizón
María Luisa Torres
Ignacio Blanco
María Teresa Martínez
Investigators of the rEXA study group
21 February 2012